Reviewed article: Fernandes RRA, Andrade KRC, Zimmermann IR. Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022. Epidemiol Serv Saude. 2026:35;e20240679
Document access evolution
Loading
Loading
Loading
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.
